TPS 100
Alternative Names: TPS-100Latest Information Update: 04 Apr 2024
At a glance
- Originator Talon Pharmaceuticals
- Class Small molecules
- Mechanism of Action Acetylcholine modulators; Dopamine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurologic gait disorders
Most Recent Events
- 25 Mar 2024 Preclinical trials in Neurologic gait disorders in Canada (PO) prior to March 2024 (Talon Pharmaceuticals pipeline; March 2024)
- 25 Mar 2024 Talon plans phase I trial for Neurological disorders (PO) (Talon Pharmaceuticals pipeline; March 2024)